TMCI

Treace Medical Concepts INC

-$39.8M

Net Activity

Institutions Holding

118

Popularity Rank

#4111

Avg Weight

0.02%

Total Value

$48.3M

Ownership Trend

118 institutions currently hold TMCI, with 63 net buyers and 54 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

54

Net Buying Institutions

63

Key Holders

View all 118 holding institutions

Quarterly Activity

Recent Activity

+$26.1M

Total Buy Value

$33.2M

Total Sell Value

New buy28
Trim29
Add35
Sold out25

63

Net Buyers

54

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding TREACE MEDICAL CONCEPTS INC (TMCI)?
Major stakeholders currently include Armistice Capital, LLC ($8.5M), Gagnon Securities LLC ($7.0M), BlackRock, Inc. ($4.5M). Based on the latest 13F filings, there are a total of 118 tracked investment funds and institutions maintaining positions in TMCI.
What is the overall institutional sentiment toward TMCI recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $39.8M, driven by 63 managers accumulating shares while 54 reduced their exposure.
Which institutions have been selling or reducing their TMCI positions?
In the latest period, 29 funds trimmed their holdings, and 25 managers completely exited their positions. The aggregate reported sell value was $33.2M.
Are there any notable investors adding TMCI to their portfolios?
Yes, buying activity remains notable. 28 institutions opened new positions in {ticker}, and 35 existing holders added to their shares. The total reported buy value for the quarter amounted to $26.1M.

Related Stocks